MoneyWorks4Me

A fair growth of 6.80% in the revenue at Rs. 382.89 millions was reported in the September 2023 quarter as compared to Rs. 358.52 millions during year-ago period.Modest increase of 6.64% in the Net Profit was reported from. 68.66 millions to Rs. 73.22  millions.Operating profit for the quarter ended September 2023 rose to 102.00 millions as compared to 98.78 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 382.89 358.52 6.80 674.64 669.84 0.72 1367.49 1239.80 10.30
Other Income 10.96 12.61 -13.08 21.33 24.04 -11.27 51.23 49.49 3.52
PBIDT 102.00 98.78 3.26 182.05 182.93 -0.48 354.90 322.04 10.20
Interest 0.69 0.94 -26.60 1.43 1.81 -20.99 3.67 4.35 -15.63
PBDT 101.31 97.84 3.55 180.62 181.12 -0.28 351.23 317.69 10.56
Depreciation 5.91 5.45 8.44 10.91 10.80 1.02 22.59 18.99 18.96
PBT 95.40 92.39 3.26 169.71 170.32 -0.36 328.64 298.70 10.02
TAX 22.18 23.73 -6.53 42.79 42.13 1.57 82.58 75.74 9.03
Deferred Tax -3.48 -1.27 174.02 -2.89 -2.10 37.62 -2.25 2.96 -176.01
PAT 73.22 68.66 6.64 126.92 128.19 -0.99 246.06 222.96 10.36
Equity 44.13 45.89 -3.84 44.13 45.89 -3.84 44.13 45.89 -3.84
PBIDTM(%) 26.64 27.55 -3.31 26.98 27.31 -1.19 25.95 25.98 -0.09
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..